Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 241–260 of 18,048 recalls
Padagis US LLC
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Direct Rx
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
SUN PHARMACEUTICAL INDUSTRIES INC
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.